InfuSystem vs OraSure Technologies
InfuSystem reported revenue of $143 million in fiscal 2025, 1.2 times OraSure Technologies' $115 million in fiscal 2025. InfuSystem's revenue grew 6.4% in its latest year, and OraSure Technologies' fell 38.1%. InfuSystem had an operating margin of 8.3%, against -62.6% at OraSure Technologies. Free cash flow was $24 million at InfuSystem and −$53 million at OraSure Technologies.
Side by side
| InfuSystem | OraSure Technologies | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $143M | $115M |
| Revenue growth | 6.4% | −38.1% |
| Revenue growth a year, last 5 years | 8.0% | −7.7% |
| Gross margin | 56.0% | 41.9% |
| Operating margin | 8.3% | −62.6% |
| Net margin | 4.6% | −59.8% |
| Free cash flow | $24M | −$53M |
| Free cash flow margin | 16.6% | −46.3% |
| Return on capital | 9.6% | — |
| Net debt to EBITDA | 0.7x | — |
| Dividends and buybacks | $10M | $15M |
| Change in diluted share count | −2.8% | −1.3% |
| Last close | $14.06 | $3.61 |
| P/E at the last close | 32.0× | — |
| Insider trades, last 12 months | bought $150,396, sold $0 | bought $456,495, sold $0 |
| Piotroski F-score | 8 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
InfuSystemOraSure Technologies
Operating margin
Percent of revenue
InfuSystemOraSure Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InfuSystemOraSure Technologies
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the InfuSystem and OraSure Technologies pages.